
Rezolute
Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.
About
Rezolute is a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for patients suffering from debilitating metabolic diseases. Their primary focus is on hyperinsulinism-related hypoglycemia and diabetic retinal disease. The company's lead candidate, ersodetug, is an antibody therapy targeting insulin receptor signaling to reduce the clinical impact of excess insulin.
Similar companies
Pioneering vision restoration therapies for severe retinal degenerations.
Shares Biotech, Drug Discovery
Biotechnology company focused on developing treatments for rare metabolic diseases.
Shares Biotech, MedTech
Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
Shares Biotech, MedTech
Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
Shares Biotech, Drug Discovery
A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
Shares Biotech, MedTech
A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
Shares Biotech, MedTech
Key facts
- Website
- rezolute.com
- Headquarters
- Redwood City, United States
- Founded
- 2012
- Employees
- 5
- Total funding
- $220M (Offering)
- Business model
- B2B
Rezolute pricing
| Plan | Price |
|---|---|
| Plugin UpdatesUp to 30 minutes per month | $80 / month |
| 1 Hour/mo1 hour per month | $175/hr / month |
| 3 Hours/mo3 hours per month | $173/hr / month |
| 5 Hours/mo5 hours per month | $170/hr / month |
| 15 Hours/mo15 hours per month | $160/hr / month |
| 30 Hours/mo30 hours per month | $150/hr / month |
Monthly hours do not roll over. Month-to-month with no long-term commitment, cancel anytime. Subscribers receive discounted hourly rates, priority scheduling, and exclusive access to ticketing system.
Plans as published by Rezolute, checked September 2026. Current prices on rezolute.com
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 23 Apr 2025 | Offering | $90M | Guggenheim Partners |
| 2 May 2022 | Series B | $130M |
Tech stack
Detected on rezolute.com, last scanned 22 Oct 2026. Run your own scan
- Compliance
- GDPR
- Frontend
- jQuery
- Analytics
- Google Analytics 4, Google Tag Manager, Meta Pixel
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Rezolute trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Rezolute is 80 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Rezolute raised?
Rezolute has raised a total of $220M in funding. The most recent round on record is Offering.
How many employees does Rezolute have?
Rezolute has approximately 5 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Rezolute:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

